Microcarrier Market Report 2026

The microcarrier market size has grown rapidly in recent years. It will grow from $2.37 billion in 2025 to $2.64 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to adoption of cell therapy research, increasing demand for vaccine production, growth of biotechnology research, availability of basic microcarrier materials, expansion of contract research organizations.

The microcarrier market size is expected to see rapid growth in the next few years. It will grow to $4.15 billion in 2030 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to rising need for personalized medicine, advancement in bioreactor technologies, integration of ai in cell culture monitoring, increasing investment in cell therapy, development of novel microcarrier materials. Major trends in the forecast period include scalable cell expansion techniques, enhanced microcarrier biocompatibility, automated cell culture systems, integration of 3D cell culture models, development of specialty microcarriers.

The rising prevalence of cancer cases is driving the growth of the microcarrier market. One of the main factors contributing to increased cancer risk is longer life expectancy. In addition, the adoption of Western lifestyles, unhealthy dietary patterns, higher dairy consumption, food additives, frequent non-vegetarian diets, environmental pollution, and insufficient physical activity have all contributed to the global rise in cancer incidence. The growing number of cancer cases involves uncontrolled cell growth that extends beyond normal boundaries to invade organs and tissues throughout the body. Microcarriers provide a support matrix that enables adherent cells to proliferate in bioreactors, supporting cancer cell growth as well as the formation of microtissues used in the repair and regeneration of damaged or degenerated tissues. For example, in February 2024, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that more than 35 million new cancer cases are projected in 2025, representing a 77% increase compared to the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is contributing to the growth of the microcarrier market.

Major companies operating in the microcarriers market are concentrating on the development of innovative products, such as polyvinyl alcohol (PVA) hydrogel microcarriers, to expand their product portfolios and increase revenue. PVA hydrogel microcarriers are biocompatible materials designed to support the attachment, growth, and expansion of adherent cells in bioprocessing and cell culture applications. For example, in October 2023, Kuraray Co., Ltd., a Japan-based chemical manufacturer, developed PVA hydrogel microcarriers for use in cell culture within the regenerative medicine sector. When introduced into bioreactors for large-scale cell cultivation, these microcarriers promote efficient cell adhesion and proliferation on their surfaces while simplifying cell detachment and recovery processes. They are recognized for their durability under bioreactor conditions, strong safety profile, and ability to improve overall cell culture efficiency.

In June 2023, Saint-Gobain Life Sciences, a US-based manufacturer of fluid management solutions and components, announced an expanded investment and service agreement with denovoMATRIX GmbH, a Germany-based microcarrier manufacturing company, to support the development of products for the stem cell therapy sector. Under the extended partnership, which runs through 2026, the companies will focus on developing protocols and products for the autologous stem cell therapy market, combining Saint-Gobain Life Sciences’ VueLife cell culture bags with denovoMATRIX’s coated microcarriers.

Major companies operating in the microcarrier market are Thermo Fisher Scientific Inc., The Merck Group, GE Healthcare Technologies Inc., Corning Incorporated, Lonza Group AG, Microcarrier Global, Sartorius AG, Getinge AB, ChemoMetec, Cesco Bioengineering Co. Ltd., Himedia Laboratories Pvt. LTtd., Esco VacciXcell, Danaher Corporation, Eppendorf AG, Solida Biotech GmbH, CellGenix GmbH, FUJIFILM Irvine Scientific Inc., Stemcell Technologies Inc., Bio-Techne Corporation, InVitria Inc., CytoSMART Technologies BV, Synthace Limited, Cell Guidance Systems Ltd., BioLamina AB, Cell Culture Company LLC, Cell Applications Inc., CellSystems Biotechnologie Vertrieb GmbH, Cellon SA, Repligen corporation, VWR International.

North America was the largest region in the microcarrier market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microcarrier market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microcarrier market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the microcarrier market by increasing the cost of imported raw materials and specialized equipment, thereby affecting overall production costs. The pharmaceutical and biotechnology companies, particularly in regions like europe and asia-pacific, face higher operational expenses. Segments such as bioreactors, microcarrier culture systems, and consumables are most affected, while some local manufacturers benefit from increased domestic demand due to cost-competitive alternatives, driving regional production and innovation.

The microcarrier market research report is one of a series of new reports that provides microcarrier market statistics, including microcarrier industry global market size, regional shares, competitors with a microcarrier market share, detailed microcarrier market segments, market trends and opportunities, and any further data you may need to thrive in the microcarrier industry. This microcarrier market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Microcarriers are support matrices that enable adherent cells to proliferate within bioreactors. They provide anchorage or a surface for attachment in suspended cell cultures, which helps maintain cell viability. Microcarriers support the expansion of cell numbers while preserving the appropriate cell phenotype required for tissue repair and functional restoration.

The primary microcarrier products include equipment and consumables. Microcarrier equipment is used to adjust the rate and efficiency of cell attachment, facilitating adherence for a wide range of cell types. Microcarriers are available in various types, including cationic microcarriers, collagen-coated microcarriers, protein-coated microcarriers, untreated microcarriers, and others. These microcarriers are manufactured using materials such as alginate-based, collagen-based, dextran-based, polystyrene-based, and other material types. They are applied in areas such as vaccine production, cell therapy, and other applications, and are utilized by pharmaceutical and biotechnology companies, research institutes, and contract research organizations (CROs).

The microcarrier market consist of sales of gelatin-based, plastic-based and glass-based microcarrier. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.